Skip to main content

Vitekta

elvitegravir
Used for HIV Treatment

Elvitegravir (Vitekta) is an oral HIV antiretroviral (ARV) medication; however, it's no longer available as a tablet on its own because it was discontinued.

Reviewed by:Last reviewed on November 16, 2021
basics-icon

What is Elvitegravir (Vitekta)?

Drug facts

Common BrandsVitekta
Drug ClassHIV ARV
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityDiscontinued
pharmacist-tips-icon

Pharmacist tips for Elvitegravir (Vitekta)

pharmacist
faq-icon

Common questions about Elvitegravir (Vitekta)

Elvitegravir (Vitekta) is an HIV ARV integrase inhibitor. It prevents HIV from inserting itself into your DNA. This way, the virus can't grow and spread in your body.

Elvitegravir (Vitekta) is no longer available as a stand-alone tablet. It's still available in HIV ARV combination tablets such as Genvoya and Stribild.

Gilead, the manufacturer, stopped making elvitegravir (Vitekta) tablets in 2017. They chose to stop making the stand-alone tablet since most people take HIV ARV combination tablets. Their decision had nothing to do with safety of the medication.

educational-icon

How to save using GoodRx

Compare Prices
1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
Select your free coupon
2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
Show coupon to your pharmacist
3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
Get free couponLearn more
dosage-icon

Elvitegravir (Vitekta) dosage

Typical dosage for Elvitegravir (Vitekta)

Get savings updates for Elvitegravir (Vitekta)

Receive price alerts, news, and other messages from GoodRx about Elvitegravir (Vitekta) and other healthcare topics and relevant savings offers.

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.